nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial
|
Smits, Pieter Cornelis |
|
2013 |
381 |
9867 |
p. 651-660 10 p. |
artikel |
2 |
A manifesto for maternal health post-2015
|
Langer, Ana |
|
2013 |
381 |
9867 |
p. 601-602 2 p. |
artikel |
3 |
Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II
|
Farooq, Vasim |
|
2013 |
381 |
9867 |
p. 639-650 12 p. |
artikel |
4 |
Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial
|
Christiansen, Evald Høj |
|
2013 |
381 |
9867 |
p. 661-669 9 p. |
artikel |
5 |
CABG or stents in coronary artery disease: end of the debate?
|
Taggart, David P |
|
2013 |
381 |
9867 |
p. 605-607 3 p. |
artikel |
6 |
Carissa Etienne: taking the reins at PAHO
|
Holmes, David |
|
2013 |
381 |
9867 |
p. 619- 1 p. |
artikel |
7 |
Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial
|
Mohr, Friedrich W |
|
2013 |
381 |
9867 |
p. 629-638 10 p. |
artikel |
8 |
Degradable polymer drug-eluting stents: a durable benefit?
|
Mehilli, Julinda |
|
2013 |
381 |
9867 |
p. 607-609 3 p. |
artikel |
9 |
Department of Error
|
|
|
2013 |
381 |
9867 |
p. 628- 1 p. |
artikel |
10 |
Department of Error
|
|
|
2013 |
381 |
9867 |
p. 628- 1 p. |
artikel |
11 |
Department of Error
|
|
|
2013 |
381 |
9867 |
p. 628- 1 p. |
artikel |
12 |
Department of Error
|
|
|
2013 |
381 |
9867 |
p. 628- 1 p. |
artikel |
13 |
Department of Error
|
|
|
2013 |
381 |
9867 |
p. 628- 1 p. |
artikel |
14 |
Department of Error
|
|
|
2013 |
381 |
9867 |
p. 628- 1 p. |
artikel |
15 |
Department of Error
|
|
|
2013 |
381 |
9867 |
p. 628- 1 p. |
artikel |
16 |
February 23–March 1, 2013
|
|
|
2013 |
381 |
9867 |
p. i- 1 p. |
artikel |
17 |
Gabapentin for refractory chronic cough
|
Brown, James P |
|
2013 |
381 |
9867 |
p. 623-624 2 p. |
artikel |
18 |
Gabapentin for refractory chronic cough
|
Abdulqawi, Rayid |
|
2013 |
381 |
9867 |
p. 623- 1 p. |
artikel |
19 |
Gabapentin for refractory chronic cough
|
Inoue, Ken-ichiro |
|
2013 |
381 |
9867 |
p. 623- 1 p. |
artikel |
20 |
Gabapentin for refractory chronic cough – Authors' reply
|
Ryan, Nicole M |
|
2013 |
381 |
9867 |
p. 624-625 2 p. |
artikel |
21 |
Gavin Hunter Mooney
|
Pincock, Stephen |
|
2013 |
381 |
9867 |
p. 622- 1 p. |
artikel |
22 |
How and when to help children cope with trauma?
|
The Lancet, |
|
2013 |
381 |
9867 |
p. 600- 1 p. |
artikel |
23 |
Illness through the eye of the artist
|
O'Brien, Eoin |
|
2013 |
381 |
9867 |
p. 618- 1 p. |
artikel |
24 |
Improving responsiveness of health systems to non-communicable diseases
|
Atun, Rifat |
|
2013 |
381 |
9867 |
p. 690-697 8 p. |
artikel |
25 |
Independent global accountability for NCDs
|
Beaglehole, Robert |
|
2013 |
381 |
9867 |
p. 602-605 4 p. |
artikel |
26 |
Maternal underweight and child growth and development
|
Razak, Fahad |
|
2013 |
381 |
9867 |
p. 626-627 2 p. |
artikel |
27 |
Maternal underweight and child growth and development – Authors' reply
|
Cresswell, Jenny A |
|
2013 |
381 |
9867 |
p. 627- 1 p. |
artikel |
28 |
New set of Alzheimer's trials focus on prevention
|
Corbyn, Zoë |
|
2013 |
381 |
9867 |
p. 614-615 2 p. |
artikel |
29 |
Offline: The darker corners of our world
|
Horton, Richard |
|
2013 |
381 |
9867 |
p. 612- 1 p. |
artikel |
30 |
Ogilvie's syndrome in severe dengue
|
Anam, Ahmad Mursel |
|
2013 |
381 |
9867 |
p. 698- 1 p. |
artikel |
31 |
Profile: ECCRI—cardiovascular research at the heart of Emory
|
Arnold, Carrie |
|
2013 |
381 |
9867 |
p. 616- 1 p. |
artikel |
32 |
Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries
|
Moodie, Rob |
|
2013 |
381 |
9867 |
p. 670-679 10 p. |
artikel |
33 |
Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration
|
Hogerzeil, Hans V |
|
2013 |
381 |
9867 |
p. 680-689 10 p. |
artikel |
34 |
Resistance to second-line drugs in multidrug-resistant tuberculosis
|
Udwadia, Zarir |
|
2013 |
381 |
9867 |
p. 625-626 2 p. |
artikel |
35 |
Resistance to second-line drugs in multidrug-resistant tuberculosis
|
Nyang'wa, Bern-Thomas |
|
2013 |
381 |
9867 |
p. 625- 1 p. |
artikel |
36 |
Resistance to second-line drugs in multidrug-resistant tuberculosis – Authors' reply
|
Dalton, Tracy |
|
2013 |
381 |
9867 |
p. 626- 1 p. |
artikel |
37 |
SORT OUT V: a new episode in the DES wars
|
Kastrati, Adnan |
|
2013 |
381 |
9867 |
p. 609-611 3 p. |
artikel |
38 |
Strengthening global action against poor quality drugs
|
The Lancet, |
|
2013 |
381 |
9867 |
p. 599- 1 p. |
artikel |
39 |
The threat of lung cancer in European women
|
The Lancet, |
|
2013 |
381 |
9867 |
p. 600- 1 p. |
artikel |
40 |
UNDP to re-engineer funding strategy
|
McCall, Becky |
|
2013 |
381 |
9867 |
p. 613- 1 p. |
artikel |
41 |
UNITAID can address HCV/HIV co-infection
|
von Schoen-Angerer, Tido |
|
2013 |
381 |
9867 |
p. 628- 1 p. |
artikel |
42 |
Voices of hope
|
Farrar, Renee |
|
2013 |
381 |
9867 |
p. 617- 1 p. |
artikel |
43 |
William Harvey goes back to the future
|
Wright, Thomas |
|
2013 |
381 |
9867 |
p. 620-621 2 p. |
artikel |